CBOA
TVRD

Commonwealth Bank of Australia’s Tvardi Therapeutics TVRD Stock Holding History

Commonwealth Bank of Australia’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-778
Closed -$521K – 1045
2014
Q1 		$521K Buy
+778
New +$460K ﹤0.01% 1029

Other funds holding TVRD

RCP
Rho Capital Partners New York $20.4M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.69% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Commonwealth Bank of Australia's TVRD Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Tvardi Therapeutics (TVRD) in Q2 2014, closing a stake of 778 shares — an estimated $521K sold.

Commonwealth Bank of Australia first reported a position in TVRD in Q1 2014 and held it in 1 quarter. The position peaked at $521K in Q1 2014. 49 funds tracked by Wall St. Rank hold TVRD as of Q2 2014.

  • Commonwealth Bank of Australia reported no remaining Tvardi Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 778 Tvardi Therapeutics shares in Q2 2014, an estimated $521K.
  • Commonwealth Bank of Australia first reported a position in Tvardi Therapeutics in Q1 2014 and held it in 1 quarter.
  • Commonwealth Bank of Australia's Tvardi Therapeutics position peaked at $521K in Q1 2014.
  • 49 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.